PepGen Ltd (PEPG) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.24
• Market Cap: $439.99M
• EPS: $-2.86
• 52-Week High: $7.80
• 52-Week Low: $0.88

Market Sentiment

PepGen Ltd currently has a Neutral sentiment score of 0.06.

About PepGen Ltd

PepGen Ltd is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, committed to developing cutting-edge oligonucleotide therapeutics targeting severe neurological and neuromuscular diseases. The company's robust pipeline illustrates its innovative approach and its potential to significantly advance treatment options in areas with high unmet medical needs. By leveraging its proprietary technologies and focusing on precision medicine, PepGen is poised to deliver tra...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for PepGen Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PEPG pay dividends?

PepGen Ltd (PEPG) does not currently pay a regular dividend.

What is PEPG's market cap?

PepGen Ltd (PEPG) has a market capitalization of $439.99M with a current stock price of $6.24.